Roth M - Search Results

1

Evidence for continuous stimulation of interleukin-6 production in Crohn's disease.

Gross V, Andus T, Caesar I, Roth M, Schölmerich J. Gross V, et al. Among authors: roth m. Gastroenterology. 1992 Feb;102(2):514-9. doi: 10.1016/0016-5085(92)90098-j. Gastroenterology. 1992. PMID: 1370661

2

A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease.

Rump JA, Schölmerich J, Gross V, Roth M, Helfesrieder R, Rautmann A, Lüdemann J, Gross WL, Peter HH. Rump JA, et al. Among authors: roth m. Immunobiology. 1990 Nov;181(4-5):406-13. doi: 10.1016/S0171-2985(11)80509-7. Immunobiology. 1990. PMID: 2099908

3

Focal white-matter lesions in brain of patients with inflammatory bowel disease.

Geissler A, Andus T, Roth M, Kullmann F, Caesar I, Held P, Gross V, Feuerbach S, Schölmerich J. Geissler A, et al. Among authors: roth m. Lancet. 1995 Apr 8;345(8954):897-8. doi: 10.1016/s0140-6736(95)90013-6. Lancet. 1995. PMID: 7707814

4

Distinct patterns of immunoglobulin classes and IgG subclasses of autoantibodies in patients with inflammatory bowel disease.

Müller-Ladner U, Gross V, Andus T, Gschwendtner H, Roth M, Caesar I, Schölmerich J, Lang B. Müller-Ladner U, et al. Among authors: roth m. Eur J Gastroenterol Hepatol. 1996 Jun;8(6):579-84. doi: 10.1097/00042737-199606000-00016. Eur J Gastroenterol Hepatol. 1996. PMID: 8823574

5

No evidence for abnormal gallbladder emptying in Crohn's disease.

Maurer P, Haag K, Roth M, Kuder C, Schölmerich J. Maurer P, et al. Among authors: roth m. Hepatogastroenterology. 1996 Jul-Aug;43(10):807-12. Hepatogastroenterology. 1996. PMID: 8884294

6

Treatment of active and postactive ileal and colonic Crohn's disease with oral pH-modified-release budesonide. German Budesonide Study Group.

Caesar I, Gross V, Roth M, Andus T, Schmidt C, Raedsch R, Weber A, Gierend M, Ewe K, Schölmerich J. Caesar I, et al. Among authors: roth m. Hepatogastroenterology. 1997 Mar-Apr;44(14):445-51. Hepatogastroenterology. 1997. PMID: 9164517 Clinical Trial.

7

[A new type of ANCA in sera of patients with ulcerative colitis: effects of therapy and disease severity on serum titer].

Rump JA, Roth M, Schölmerich J, Helfesrieder R, Lüdemann J, Gross WL, Rautmann A, Peter HH. Rump JA, et al. Among authors: roth m. Immun Infekt. 1992 Feb;20(1):16-8. Immun Infekt. 1992. PMID: 1563754 German.

8

Inflammatory mediators in chronic inflammatory bowel diseases.

Gross V, Andus T, Leser HG, Roth M, Schölmerich J. Gross V, et al. Among authors: roth m. Klin Wochenschr. 1991 Dec 15;69(21-23):981-7. doi: 10.1007/BF01645143. Klin Wochenschr. 1991. PMID: 1798295 Review.

9

Treatment of active Crohn's ileocolitis with oral pH-modified budesonide. Germany Budesonide Study Group.

Caesar I, Gross V, Roth M, Andus T, Schmidt C, Raedsch R, Weber A, Gierend M, Ewe K, Schölmerich J. Caesar I, et al. Among authors: roth m. Z Gastroenterol. 1995 May;33(5):247-50. Z Gastroenterol. 1995. PMID: 7610691

10

p-ANCA of undefined specificity in ulcerative colitis: correlation to disease activity and therapy.

Rump JA, Wörner I, Roth M, Schölmerich J, Hänsch M, Peter HH. Rump JA, et al. Among authors: roth m. Adv Exp Med Biol. 1993;336:507-13. doi: 10.1007/978-1-4757-9182-2_92. Adv Exp Med Biol. 1993. PMID: 8296665

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,940 results

Search Page

Filters